Dark

Check out our Dark Pool Levels

BIOAF
BIOASIS TECHNOLOGIES INC
stock OTC

Inactive

Jun 17, 2025

0.000001USD-99.500%(-0.000199)2,500

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 20, 2022

05:01PM EST Bioasis Announces Filing of Its Quarter and Financial Statements GlobeNewswire Inc

Dec 16, 2021

04:31PM EST Bioasis Announces Annual General Meeting Results GlobeNewswire Inc

Dec 9, 2021

04:30PM EST Bioasis to Attend and Present at Upcoming Industry Conferences GlobeNewswire Inc

Nov 29, 2021

04:30PM EST Bioasis Announces Annual General Meeting Details GlobeNewswire Inc

Sep 30, 2021

04:05PM EDT Bioasis to Attend Upcoming Industry Conferences GlobeNewswire Inc

Aug 18, 2021

04:05PM EDT Bioasis Technologies Inc. Announces the Appointment of Shadow Lake GlobeNewswire Inc

Jul 20, 2021

04:05PM EDT Bioasis Technologies Inc. Announces Stock Option Grants, Jeffrey GlobeNewswire Inc

Jul 7, 2021

04:05PM EDT Bioasis Announces Positive Results From an Efficacy Study of GlobeNewswire Inc

Jul 1, 2021

04:05PM EDT Bioasis Announces the Appointment of Dave Jenkins as Chief GlobeNewswire Inc

Jun 30, 2021

04:05PM EDT Bioasis Technologies Inc. (TSXV:BTI; OTCQB:BIOAF) (Bioasis) and Oxyrane UK Ltd. (Oxyrane) are pleased to announce the initiation of a research collaboration. GlobeNewswire Inc

Jun 29, 2021

04:05PM EDT Bioasis Technologies Announces Closing of Initial C$3,000,000 GlobeNewswire Inc

Jun 25, 2021

05:33PM EDT Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End GlobeNewswire Inc

Jun 22, 2021

08:13PM EDT Bioasis Technologies enters into Convertible Security Funding GlobeNewswire Inc

Jun 3, 2021

04:05PM EDT Bioasis Announces Publication Validating its xB GlobeNewswire Inc

Mar 31, 2021

04:05PM EDT Bioasis Technologies Inc. and Aposense Enter into a Research GlobeNewswire Inc

Mar 29, 2021

04:05PM EDT Bioasis Announces Publication of CNS Delivery of siRNA via GlobeNewswire Inc

Mar 24, 2021

05:16PM EDT Bioasis Technologies Inc. Confirms TSXV Approval of Warrant GlobeNewswire Inc

Mar 22, 2021

06:30PM EDT Bioasis Technologies Inc. Announces Warrant Extension and Repricing GlobeNewswire Inc

Mar 8, 2021

04:05PM EST Bioasis to Attend and Present at Upcoming Investor and Industry GlobeNewswire Inc

Feb 10, 2021

07:02PM EST Bioasis Announces Shares for Debt Transaction GlobeNewswire Inc

Jan 29, 2021

04:05PM EST Bioasis Announces $200,000 Non-Brokered Private Placement GlobeNewswire Inc

Jan 27, 2021

04:05PM EST Bioasis Announces Filing of Its Quarter and Financial Statements GlobeNewswire Inc

Jan 22, 2021

09:19AM EST Bioasis Announces Stock Option Grant GlobeNewswire Inc

Jan 4, 2021

04:05PM EST Bioasis to Present at Upcoming Industry Conferences GlobeNewswire Inc

Dec 10, 2020

04:05PM EST Bioasis Announces Annual General Meeting Results GlobeNewswire Inc

Nov 10, 2020

04:05PM EST Bioasis Announces Annual General Meeting Details GlobeNewswire Inc

Nov 3, 2020

04:05PM EST Bioasis Announces Sale of Royalty Interest in Lysosomal Storage GlobeNewswire Inc

07:30AM EST XOMA Corporation (NASDAQ: XOMA), announced today it has acquired the rights to future milestone and royalty revenue due to Bioasis Technologies Inc. (TSXV:BTI.V; OTCQB:BIOAF), associated with the advancement of the enzymes being investigated as potential treatments for four different lysosomal storage disorders (LSD) under Bioasis strategic alliance with Chiesi Group. GlobeNewswire Inc

Oct 22, 2020

04:05PM EDT Bioasis Announces Analyst Coverage Initiated by Zacks Investment GlobeNewswire Inc

Oct 20, 2020

04:05PM EDT Bioasis Announces Issuance of US Patent Relating to GlobeNewswire Inc

Jul 27, 2020

05:03PM EDT Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending May 31, 2020 Business Wire

Share